Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Total Non-Current Liabilities (2011 - 2026)

Updated

Iovance Biotherapeutics (IOVA) reported Total Non-Current Liabilities of $72.64 million for Q2 2026, down 9.0% from $79.79 million a year earlier and down 2.5% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025, Iovance Biotherapeutics posted Total Non-Current Liabilities of $76.23 million, down 1.9% from FY2024.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $77.68 million in FY2024 (-9.1%), $85.43 million in FY2023 (+17.3%), $72.86 million in FY2022 (+9.6%) and $66.47 million in FY2021 (+16.4%).
  • The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since Q1 2023.
  • Year over year, Total Non-Current Liabilities has now declined in each of the last three quarters, with an average decline of 10.1% over the last five quarters.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q3 2021 (growth of 984.1%); the low point was Q1 2025 (a decline of 28.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $74.49 million (Q1 2026), $76.23 million (Q4 2025) and $76.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn 72.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 72.64 Mn
Mar 31, 2026 74.49 Mn
Dec 31, 2025 76.23 Mn
Sep 30, 2025 76.88 Mn
Jun 30, 2025 79.79 Mn
Mar 31, 2025 76.18 Mn
Dec 31, 2024 77.68 Mn
Mar 31, 2024 106.59 Mn
Dec 31, 2023 85.43 Mn
Sep 30, 2023 87.35 Mn
Jun 30, 2023 90.08 Mn
Mar 31, 2023 70.61 Mn
Dec 31, 2022 72.86 Mn
Sep 30, 2022 72.94 Mn
Jun 30, 2022 74.00 Mn
Mar 31, 2022 72.18 Mn
Dec 31, 2021 66.47 Mn
Sep 30, 2021 65.73 Mn
Jun 30, 2021 47.84 Mn
Mar 31, 2021 48.08 Mn
API Access

Iovance Biotherapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IOVA&period=max&api_key=YOUR_API_KEY